Amarin to Report Fourth Quarter and Full-Year 2015 Results and Host Conference Call on February 25, 2016
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - February 18, 2016) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced …